SCHEMBL7013495

SCHEMBL7013495

COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3n2S(=O)(=O)c2ccc(OCC(N)=O)cc2)c1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
HTT P42858 2/20 0.43
TP53 P04637 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
TSHR P16473 2/20 0.43
MAPK1 P28482 1/20 0.43
NOD1 Q9Y239 4/20 0.38
CXCL8 P10145 2/20 0.38
KMT2A Q03164 3/20 0.38
CYP2C9 P11712 2/20 0.38
HPGD P15428 2/20 0.38
MAPT P10636 2/20 0.38
WDR5 P61964 2/20 0.38
DDAH1 O94760 1/20 0.38
LMNA P02545 1/20 0.38
HTR1A P08908 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
IDE P14735 1/20 0.38
ADRA2B P18089 1/20 0.38
TBXA2R P21731 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5763411 0.93 ALDH1A1 (0.44) ALDH1A1HTTTP53SMN1; SMN2TSHR
SCHEMBL5763423 0.93 ALDH1A1 (0.44) ALDH1A1HTTTP53SMN1; SMN2TSHR
SCHEMBL13053533 0.93 ALDH1A1 (0.44) ALDH1A1HTTTP53SMN1; SMN2TSHR
SCHEMBL5763405 0.93 ALDH1A1 (0.43) ALDH1A1HTTTP53SMN1; SMN2TSHR
SCHEMBL7012259 0.92 SMN1; SMN2 (0.40) ALDH1A1HTTTP53SMN1; SMN2TSHR
SCHEMBL7233208 0.91 ALDH3A1 (0.38) ALDH1A1HTTTP53SMN1; SMN2TSHR
SCHEMBL7011328 0.88 ALDH1A1 (0.38) ALDH1A1HTTTP53SMN1; SMN2TSHR
SCHEMBL7010552 0.88 MAPT (0.44) ALDH1A1HTTTP53SMN1; SMN2TSHR
SCHEMBL7011482 0.88 ALDH1A1 (0.40) ALDH1A1HTTTP53SMN1; SMN2TSHR
SCHEMBL5763540 0.87 ALDH1A1 (0.41) ALDH1A1HTTTP53SMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6559167-B1 Prodrugs of the pyridyl methyl sulfinyl benzimidazole type proton pump inhibitor drugs have a hydrolyzable arylsulfonyl or heteroarylsulfonyl group attached to the benzimidazole nitrogen. The prodrugs of the invention hydrolyze under REGENTS OF THE UNIVERSITY OF CALIFORNIA 2003-05-06 US claimed
EP-1105387-B1 PRODRUGS OF PROTON PUMP INHIBITORS WINSTON PHARMATEUTICALS LLC (US) 2003-01-29 EP claimed
US-6559167-B1 Prodrugs of the pyridyl methyl sulfinyl benzimidazole type proton pump inhibitor drugs have a hydrolyzable arylsulfonyl or heteroarylsulfonyl group attached to the benzimidazole nitrogen. The prodrugs of the invention hydrolyze under REGENTS OF THE UNIVERSITY OF CALIFORNIA 2003-05-06 US disclosed
EP-1105387-B1 PRODRUGS OF PROTON PUMP INHIBITORS WINSTON PHARMATEUTICALS LLC (US) 2003-01-29 EP disclosed